Cargando…

Potential Benefits of Therapeutic Use of β2-Adrenergic Receptor Agonists in Neuroprotection and Parkinsonμs Disease

The β2-adrenergic receptor (β2AR) is a seven-transmembrane (7TM) G-protein coupled receptor that is expressed on cells of the pulmonary, cardiac, skeletal muscle, and immune systems. Previous work has shown that stimulation of this receptor on immune cells has profound effects on the regulatory acti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peterson, Lynda, Ismond, Kathleen P., Chapman, Elisha, Flood, Patrick
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3987873/ https://www.ncbi.nlm.nih.gov/pubmed/24741572 http://dx.doi.org/10.1155/2014/103780

Ejemplares similares

Agonist-Directed Desensitization of the β(2)-Adrenergic Receptor
por: Goral, Vasiliy, et al.
Publicado: (2011)

Oxidative Stress and Microglial Cells in Parkinson's Disease
por: Peterson, Lynda J., et al.
Publicado: (2012)

The structural basis for agonist and partial agonist action on a β(1)-adrenergic receptor
por: Warne, Tony, et al.
Publicado: (2011)

Non-amyloidogenic effects of α2 adrenergic agonists: implications for brimonidine-mediated neuroprotection
por: Nizari, Shereen, et al.
Publicado: (2016)

β-agonists for ARDS: the dark side of adrenergic stimulation?
por: Thompson, B Taylor
Publicado: (2012)

Characterization of β-adrenergic receptors in bovine intramuscular and subcutaneous adipose tissue: comparison of lubabegron fumarate with β-adrenergic receptor agonists and antagonists
por: Hwang, Jinhee H, et al.
Publicado: (2021)

Beta-Adrenergic Agonists
por: Barisione, Giovanni, et al.
Publicado: (2010)

Simulations of Biased Agonists in the β(2) Adrenergic Receptor with Accelerated Molecular Dynamics
por: Tikhonova, Irina G., et al.
Publicado: (2013)

The Effects of Inhaled β-Adrenergic Agonists in Transient Tachypnea of the Newborn
por: Keleş, Esengul, et al.
Publicado: (2016)

Prenatal exposure to β2-adrenergic receptor agonists and risk of autism spectrum disorders
por: Croen, Lisa A., et al.
Publicado: (2011)

The effect of adrenergic β(2) receptor agonist on paraplegia following clamping of abdominal aorta
por: Lee, Bok Y., et al.
Publicado: (2011)

Forearm vasodilator responses to a β‐adrenergic receptor agonist in premenopausal and postmenopausal women
por: Harvey, Ronee E., et al.
Publicado: (2014)

Agonistic Autoantibodies to the β2-Adrenergic Receptor Involved in the Pathogenesis of Open-Angle Glaucoma
por: Jünemann, Anselm, et al.
Publicado: (2018)

Pharmacophore‐guided Virtual Screening to Identify New β(3)‐adrenergic Receptor Agonists
por: Ujiantari, Navista Sri Octa, et al.
Publicado: (2022)

β(2 )adrenergic agonists in acute lung injury? The heart of the matter
por: Lee, Jae W
Publicado: (2009)

Historical Overview of the Effect of β-Adrenergic Agonists on Beef Cattle Production
por: Johnson, Bradley J., et al.
Publicado: (2014)

β3 adrenergic receptor as potential therapeutic target in ADPKD
por: Schena, Giorgia, et al.
Publicado: (2021)

Agemone mexicana flavanones; apposite inverse agonists of the β2-adrenergic receptor in asthma treatment
por: Eniafe, Gabriel O., et al.
Publicado: (2018)

Exacerbation of ozone-induced pulmonary and systemic effects by β(2)-adrenergic and/or glucocorticoid receptor agonist/s
por: Henriquez, Andres R., et al.
Publicado: (2019)

Inhibitory and Agonistic Autoantibodies Directed Against the β(2)-Adrenergic Receptor in Pseudoexfoliation Syndrome and Glaucoma
por: Hohberger, Bettina, et al.
Publicado: (2021)

Association between use of ß2-adrenergic receptor agonists and incidence of Parkinson’s disease: Retrospective cohort analysis
por: Nadeem, Hasan, et al.
Publicado: (2022)

Agonist binding by the β(2)-adrenergic receptor: an effect of receptor conformation on ligand association–dissociation characteristics
por: Plazinska, Anita, et al.
Publicado: (2015)

Effect of β(2)-adrenergic receptor gene (ADRB2) 3′ untranslated region polymorphisms on inhaled corticosteroid/long-acting β(2)-adrenergic agonist response
por: Ambrose, Helen J, et al.
Publicado: (2012)

Evaluation of the Effect of a Novel β3-Adrenergic Agonist on Choroidal Vascularity
por: Topcuoğlu, Murat, et al.
Publicado: (2021)

QSPR analysis of some agonists and antagonists of α-adrenergic receptors
por: Kawczak, Piotr, et al.
Publicado: (2014)

Adrenergic receptor agonists/hydrocortisone: Lack of efficacy: case report
Publicado: (2021)

Identifying Ligand Binding Conformations of the β2-Adrenergic Receptor by Using Its Agonists as Computational Probes
por: Isin, Basak, et al.
Publicado: (2012)

β2-adrenergic receptor agonist counteracts skeletal muscle atrophy and oxidative stress in uremic mice
por: Higashihara, Takaaki, et al.
Publicado: (2021)

Body‐weight‐independent glucose‐lowering effect of the β3‐adrenergic receptor agonist mirabegron in humans
por: Waki, Hironori, et al.
Publicado: (2021)

Mirabegron, a Selective β3-Adrenergic Receptor Agonist, as a Potential Anti-Obesity Drug
por: Dąbrowska, Anna Maria, et al.
Publicado: (2023)

Characterization of methadone as a β-arrestin-biased μ-opioid receptor agonist
por: Doi, Seira, et al.
Publicado: (2016)

Cardioprotective Effect of Ulmus wallichiana Planchon in β-Adrenergic Agonist Induced Cardiac Hypertrophy
por: Syed, Anees A., et al.
Publicado: (2016)

Inhibition of VMAT2 by β2-adrenergic agonists, antagonists, and the atypical antipsychotic ziprasidone
por: Støve, Svein Isungset, et al.
Publicado: (2022)

Impact of thermogenesis induced by chronic β3-adrenergic receptor agonist treatment on inflammatory and infectious response during bacteremia in mice
por: Munro, Patrick, et al.
Publicado: (2021)

Synthesis and Evaluation of Novel Biased μ-Opioid-Receptor (μOR) Agonists
por: Ma, Mengjun, et al.
Publicado: (2019)

β1-adrenergic receptor stimulation by agonist Compound 49b restores insulin receptor signal transduction in vivo
por: Jiang, Youde, et al.
Publicado: (2014)

Predicting Novel Binding Modes of Agonists to β Adrenergic Receptors Using All-Atom Molecular Dynamics Simulations
por: Vanni, Stefano, et al.
Publicado: (2011)

β-adrenergic receptor agonist, Compound 49b, inhibits TLR4 signaling pathway in diabetic retina
por: Berger, Elizabeth A., et al.
Publicado: (2016)

CL316,243, a β3-adrenergic receptor agonist, induces muscle hypertrophy and increased strength
por: Puzzo, Daniela, et al.
Publicado: (2016)

β2-Adrenergic receptor agonists ameliorate the adverse effect of long-term pyridostigmine on neuromuscular junction structure
por: Vanhaesebrouck, An E, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_nnhgf1kqqg5m9ou7sei1p3qkd3